Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
TREX1 constitutes the major 3'-->5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903 · cited 5×
“3), comparable to the level seen in cells from unaffected heterozygous parents of subjects with recessive AGS.6 Our previous analyses of AGS-affected patients with biallelic TREX1 mutations indicated that AGS at the AGS1 locus results from an abrogation of TREX1 enzyme activity.6 The TREX1 protein functions as a dimer…”
BackgroundSelf-citationOnline Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Crow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Self-citationMutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470 · cited 1×
“Of note in the context of AGS, mutations in DNase I are associated with a lupus phenotype,(22) and mice deficient in DNase II accumulate undigested DNA in macrophages, with consequent IFN-b up-regulation, and recapitulate the clinical and immunological phenotype of rheumatoid arthritis.(23) We have suggested(6) that A…”
BackgroundMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380 · cited 2×
“Lymphoblastoid cell lines were established from affected individuals, and TREX1 exonuclease activity in cell extracts was measured, as described elsewhere, with use of a polydeoxynucleotide substrate.(3) Extracts of control lymphoblastoid cell lines exhibited readily detected TREX1 activity.”
BackgroundMethodSelf-citationMazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citationChowdhury, D., Beresford, P. J., Zhu, P., Zhang, D., Sung, J.-S., Demple, B., Perrino, F. W., & Lieberman, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.005 · Cited by 264
Self-citationA human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein
Hoss, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3868 · Cited by 170 · cited 3×
“Despite its position within the EXO I domain, one of three sequence motifs containing four acidic residues participating in the coordination of divalent metal ions necessary for catalysis—the phenylalanine at position 17—is not conserved in mouse Trex1 or the related human TREX2.”
BackgroundSelf-citation
Cited by
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
“AGS presents in infancy as a severe encephalitis with intracranial calcifications, lymphocyte infiltrates , and elevated type I IFN levels in cerebrospinal fluid, and demyelination of motor neurons with accompanying psychomotor retardation (Rice et al., 2007b).”
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationActivation of STING requires palmitoylation at the Golgi
Mukai, K., Konno, H., Akiba, T., Uemura, T., Waguri, S., Kobayashi, T., Barber, G. N., Arai, H., & Taguchi, T. (2016) · Nature Communications · doi:10.1038/ncomms11932 · Cited by 710
“This suggests that STING may also be involved in human autoinflammatory disorders such as Aicardi–Goutieres syndrome and systemic lupus erythematosus that are associated with mutations of human DNase III 17,18 .”
Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2091 · Cited by 730
Self-citationHärtlova, A., Erttmann, S. F., Raffi, F. A., Schmalz, A. M., Resch, U., Anugula, S., Lienenklaus, S., Nilsson, L. M., Kröger, A., Nilsson, J. A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.012 · Cited by 716
“AGS is a neurodegenerative and inflammatory disease that mimics congenital viral infection and which phenotypically overlaps with the autoimmune disease systemic lupus erythematosus (Gall et al., 2012; Rice et al., 2007).”
BackgroundRice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
“We further showed that heterozygous TREX1 mutations can cause both a dominant form of AGS and a cutaneous subtype of SLE, called familial chilblain lupus (CHBL, MIM610448”
BackgroundSelf-citationRice, G. I., del Toro Duany, Y., Jenkinson, E. M., Forte, G. M. A., Anderson, B. H., Ariaudo, G., Bader-Meunier, B., Baildam, E. M., Battini, R., Beresford, M. W., et al. (2014) · Nature Genetics · doi:10.1038/ng.2933 · Cited by 591
Self-citationCrow, Y. J., Chase, D. S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., Oojageer, A., Anderson, B., Pizzino, A., Helman, G., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36887 · Cited by 595
“In 2007 [Rice et al., 2007b], we reported a genotype-phenotype analysis of 98 caseswithpathogenic variants in the fourgenes, TREX1 [Crowet al., 2006a],RNASEH2A, RNASEH2B, and RNASEH2C [Crow et al., 2006b], known to be associated with AGS at that time.”
BackgroundSelf-citationNucleic acid recognition by the innate immune system
Barbalat, R., Ewald, S. E., Mouchess, M. L., & Barton, G. M. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101340 · Cited by 577
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
Yang, Y.-G., Lindahl, T., & Barnes, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.017 · Cited by 579
“More recently, certain heterozygous TREX1 mutations have been implicated in SLE, as well as dominant AGS and other distinct monogenic diseases (Lee-Kirsch et al., 2007a, 2007b; Rice et al., 2007a; Richards et al., 2007).”
Self-citationGall, A., Treuting, P., Elkon, K. B., Loo, Y.-M., Gale, M., Barber, G. N., & Stetson, D. B. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.018 · Cited by 510
“AGS is characterized by elevated type I IFNs, brain inflammation, and profound psychomotor retardation, with a mortality rate approaching 35% by 15 years of age (Rice et al., 2007b).”
The role of retrotransposable elements in ageing and age-associated diseases
Gorbunova, V., Seluanov, A., Mita, P., McKerrow, W., Fenyö, D., Boeke, J. D., Linker, S. B., Gage, F. H., Kreiling, J. A., Petrashen, A. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03542-y · Cited by 446
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
Rice, G., Patrick, T., Parmar, R., Taylor, C. F., Aeby, A., Aicardi, J., Artuch, R., Montalto, S. A., Bacino, C. A., Barroso, B., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521373 · Cited by 445
“Our recent description of heterozygous TREX1 mutations as a cause of dominant AGS suggests that some mutations may have a dominant negative effect.(19) Additionally, multiple patients are homozygous or compound heterozygous for a recurrent amino acid substitution, R114H, known to be involved in stabilization of the TR…”
BackgroundInfluentialSelf-citationRichards, A., van den Maagdenberg, A. M. J. M., Jen, J. C., Kavanagh, D., Bertram, P., Spitzer, D., Liszewski, M. K., Barilla-LaBarca, M.-L., Terwindt, G. M., Kasai, Y., et al. (2007) · Nature Genetics · doi:10.1038/ng2082 · Cited by 445
Restricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
“TREX1 mutations are also implicated in other autoimmune conditions, including systemic lupus erythematous, chilblain lupus, and retinal vasculopathy with cerebral leukodystrophy [494, 495].”
BackgroundType I interferonopathies: a novel set of inborn errors of immunity
Crow, Y. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06220.x · Cited by 404
Self-citationLahaye, X., Satoh, T., Gentili, M., Cerboni, S., Conrad, C., Hurbain, I., El Marjou, A., Lacabaratz, C., Lelièvre, J.-D., & Manel, N. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.002 · Cited by 390
“Innate Sensing of HIV by cGAS in Dendritic Cells for TREX1 (Yan et al., 2010), another AGS-related gene (Rice et al., 2007).”
Gray, E. E., Treuting, P. M., Woodward, J. J., & Stetson, D. B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500969 · Cited by 384
Vincent, J., Adura, C., Gao, P., Luz, A., Lama, L., Asano, Y., Okamoto, R., Imaeda, T., Aida, J., Rothamel, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00833-9 · Cited by 370
Recent Advances in the Genetics of Autoimmune Disease
Gregersen, P. K., & Olsson, L. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132653 · Cited by 339
The enemy within: endogenous retroelements and autoimmune disease
Volkman, H. E., & Stetson, D. B. (2014) · Nature Immunology · doi:10.1038/ni.2872 · Cited by 333
Type I interferon in rheumatic diseases
Muskardin, T. L. W., & Niewold, T. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.31 · Cited by 308
Familial chilblain lupus due to a gain-of-function mutation in STING
König, N., Fiehn, C., Wolf, C., Schuster, M., Cura Costa, E., Tüngler, V., Alvarez, H. A., Chara, O., Engel, K., Goldbach-Mansky, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209841 · Cited by 308
Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
Walling, H. W., & Sontheimer, R. D. (2009) · American Journal of Clinical Dermatology · doi:10.2165/11310780-000000000-00000 · Cited by 281
“A familial form is characterized by mutations in the TREX1 (endonuclease repair) gene.([32])”
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
Crow, Y. J., & Rehwinkel, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp293 · Cited by 289
“Mutations: black, recessive AGS; purple, dominant AGS; green, FCL; blue, SLE; red, RVCL. Exo1, 2, 3 domains; PII, polyproline II domain; TM, transmembrane domain.”
BackgroundSelf-citationEvaluation of the TREX1 gene in a large multi-ancestral lupus cohort
Namjou, B., Kothari, P. H., Kelly, J. A., Glenn, S. B., Ojwang, J. O., Adler, A., Alarcón-Riquelme, M. E., Gallant, C. J., Boackle, S. A., Criswell, L. A., et al. (2011) · Genes & Immunity · doi:10.1038/gene.2010.73 · Cited by 281
Self-citationCytosolic DNA Sensing in Organismal Tumor Control
Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250
“Heterozygous mutations in TREX1 have been associated with AGS and familial chilblain lupus (a cutaneous form of systemic lupus erythematosus) (Crow et al., 2006; Rice et al., 2007).”
Backgroundde Jesus, A. A., Hou, Y., Brooks, S., Malle, L., Biancotto, A., Huang, Y., Calvo, K. R., Marrero, B., Moir, S., Oler, A. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129301 · Cited by 239
“Patient G7-P3 had severe localized panniculitis, localized lipoatrophy, and basal ganglia calcifications without white matter disease, and harbored a de novo somatic mutation (~26% allele fraction) in TREX1 that was previously associated with autosomal dominant AGS1 as a germline mutation (29).”
BackgroundDefective removal of ribonucleotides from DNA promotes systemic autoimmunity
Günther, C., Kind, B., Reijns, M. A. M., Berndt, N., Martinez-Bueno, M., Wolf, C., Tüngler, V., Chara, O., Lee, Y. A., Hübner, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78001 · Cited by 222
“…cohort of set 2, this L202S variant was significantly associated with SLE, after principal component analysis to correct for stratification (Supplemental Methods) and and complex SLE (10, 14–16), we asked whether heterozygosity for RNASEH2 mutations increases the risk of systemic autoimmunity.”
BackgroundLee-Kirsch, M. A., Chowdhury, D., Harvey, S., Gong, M., Senenko, L., Engel, K., Pfeiffer, C., Hollis, T., Gahr, M., Perrino, F. W., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0199-9 · Cited by 220
Self-citationIntracellular Nucleic Acid Detection in Autoimmunity
Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E., & Stetson, D. B. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052331 · Cited by 223
“The identification of TREX1 mutations in AGS and familial chilblain lupus (64, 65) revealed a role for Trex1 as a key regulator of the antiviral response.”
BackgroundExpanding the phenotypic spectrum of lupus erythematosus in Aicardi‐Goutières syndrome
Ramantani, G., Kohlhase, J., Hertzberg, C., Innes, A. M., Engel, K., Hunger, S., Borozdin, W., Mah, J. K., Ungerath, K., Walkenhorst, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27367 · Cited by 213
STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
Klarquist, J., Hennies, C. M., Lehn, M. A., Reboulet, R. A., Feau, S., & Janssen, E. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401869 · Cited by 211
Lee-Kirsch, M. A. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104506 · Cited by 210
Phagocytosis of Necrotic Debris at Sites of Injury and Inflammation
Westman, J., Grinstein, S., & Marques, P. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03030 · Cited by 203
“In humans, mutations of DNAse I (204), DNAse IL3 (205) and DNAse III (TREX1) (206) have already been implicated in the incidence of SLE or lupus-like disease.”
BackgroundHuman Disease Phenotypes Associated With Mutations in TREX1
Rice, G. I., Rodero, M. P., & Crow, Y. J. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0147-3 · Cited by 205
“In six of seven such patients with dominant TREX1-related disease, the mutation was recorded to have occurred de novo [9, 15, 18, 19].”
BackgroundInfluentialSelf-citationGenome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome
Lim, Y. W., Sanz, L. A., Xu, X., Hartono, S. R., & Chédin, F. (2015) · eLife · doi:10.7554/elife.08007 · Cited by 188
“Aicardi–Goutières syndrome (AGS) is a severe inflammatory encephalopathy characterized by neurological dysfunction, psychomotor retardation, seizures, unexplained fevers, joint stiffness, basal ganglia calcification, and chilblain skin lesions (Rice et al., 2007b).”
BackgroundInfluentialBraunstein, I., Klein, R., Okawa, J., & Werth, V. P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10825.x · Cited by 179
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Stam, A. H., Kothari, P. H., Shaikh, A., Gschwendter, A., Jen, J. C., Hodgkinson, S., Hardy, T. A., Hayes, M., Kempster, P. A., Kotschet, K. E., et al. (2016) · Brain · doi:10.1093/brain/aww217 · Cited by 174
“Heterozygous TREX1 missense mutations are found in FCL, an autoimmune disease that primarily affects the skin (Lee-Kirsch et al. 2007a; Rice et al., 2007).”
BackgroundInnate and adaptive immune response to apoptotic cells
Peng, Y., Martin, D. A., Kenkel, J., Zhang, K., Ogden, C. A., & Elkon, K. B. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.017 · Cited by 167
“DNase 1 deficiency causes lupus on a susceptible strain background, selective deficiency of DNase II in macrophages led to arthritis in mice [49] and TREX1 mutations are associated with chilblain lupus [50].”
BackgroundRPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA
Wolf, C., Rapp, A., Berndt, N., Staroske, W., Schuster, M., Dobrick-Mattheuer, M., Kretschmer, S., König, N., Kurth, T., Wieczorek, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11752 · Cited by 161
Behrendt, R., Schumann, T., Gerbaulet, A., Nguyen, L. A., Schubert, N., Alexopoulou, D., Berka, U., Lienenklaus, S., Peschke, K., Sutter, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.037 · Cited by 179
“The finding that a rare monogenic form of lupus can also be caused by mutations in TREX1 (Lee-Kirsch et al., 2007a; Rice et al., 2007a) or SAMHD1 (Ravenscroft et al., 2011), as well as the identification of SLE patients carrying mutations in TREX1 (Lee-Kirsch et al., 2007b) and a report of the…”
PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing
Gavin, A. L., Huang, D., Huber, C., Mårtensson, A., Tardif, V., Skog, P. D., Blane, T. R., Thinnes, T. C., Osborn, K. G., Chong, H. S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0179-y · Cited by 151
A Genomic Approach to Human Autoimmune Diseases
Pascual, V., Chaussabel, D., & Banchereau, J. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101221 · Cited by 161
Chilblain lupus erythematosus—a review of literature
Hedrich, C. M., Fiebig, B., Hauck, F. H., Sallmann, S., Hahn, G., Pfeiffer, C., Heubner, G., & Gahr, M. L. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0942-9 · Cited by 139
“These novel findings indicate that certain rare mutations in TREX1 can result in a dominant phenotype with symptoms of familial CHLE, SLE or AGS [5, 6, 11].”
BackgroundInfluentialNew roles for the major human 3′-5′ exonuclease TREX1 in human disease
Kavanagh, D., Spitzer, D., Kothari, P. H., Shaikh, A., Liszewski, M. K., Richards, A., & Atkinson, J. P. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6162 · Cited by 132
Gonçalves, A., Karayel, E., Rice, G., Bennett, K. L., Crow, Y. J., Superti‐Furga, G., & Bürckstümmer, T. (2012) · Human Mutation · doi:10.1002/humu.22087 · Cited by 153
“Mutations in genes encoding the exonuclease TREX1 and the three subunits of the RNase H2 endonuclease complex (RNase H2A, RNase H2B, and RNase H2C) have been reported to cause AGS [Crow et al., 2006a, 2006b; Rice et al., 2007, 2009].”
BackgroundSelf-citationType I interferonopathies in pediatric rheumatology
Volpi, S., Picco, P. P., Caorsi, R., Candotti, F., & Gattorno, M. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0094-4 · Cited by 138
Lehtinen, D. A., Harvey, S. E., Mulcahy, M. J., Hollis, T., & Perrino, F. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806155200 · Cited by 143
Self-citationStimulator of Interferon Genes–Associated Vasculopathy With Onset in Infancy
Munoz, J., Rodière, M., Jeremiah, N., Rieux‐Laucat, F., Oojageer, A., Rice, G., Rozenberg, F., Crow, Y. J., & Bessis, D. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.0251 · Cited by 130
Self-citationThe genetics of type I interferon in systemic lupus erythematosus
Bronson, P. G., Chaivorapol, C., Ortmann, W. A., Behrens, T. W., & Graham, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.008 · Cited by 130
Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus
Ravenscroft, J., Suri, M., Rice, G., Szynkiewicz, M., & Crow, Y. J. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33778 · Cited by 135
“Interestingly, approximately 40% of patients with AGS experience chilblains, so that familial chilblain lupus (FCL) might usefully be considered as a forme fruste of AGS [Rice et al., 2007b].”
BackgroundSelf-citationAicardi‐Goutières syndrome: an important Mendelian mimic of congenital infection
Crow, Y. J., & Livingston, J. H. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.02062.x · Cited by 119
Self-citationAn autoimmune disease prevented by anti-retroviral drugs
Beck-Engeser, G. B., Eilat, D., & Wabl, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-91 · Cited by 117
“Both AGS [4], and a cutaneous subtype of SLE called familial chilblain lupus [5,6], can result from mutations in TREX1.”
BackgroundCrow, Y. J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00031-9 · Cited by 126
“Subsequent studies in mutation-positive AGS cases show that CSF neopterin is consistently raised and is a thus a reliable disease marker (Rice et al., 2007b).”
BackgroundInfluentialSelf-citationPaediatric-onset systemic lupus erythematosus
Malattia, C., & Martini, A. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2013.07.007 · Cited by 130
STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation?
Smith, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611347 · Cited by 122
“Full deletions are more likely to be associated with the severe early-onset manifestations, as in AGS, whereas heterozygous deficiencies are more common in complex milder or later onset conditions, such as familial chilblain lupus (126).”
BackgroundRamesh, V., BERNARDI, B., Stafa, A., Garone, C., Franzonı, E., Abinun, M., Mitchell, P. D., Mitra, D., Friswell, M., Nelson, J. W., et al. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03727.x · Cited by 120
Self-citationAstrocytes produce interferon‐alpha and CXCL10, but not IL‐6 or CXCL8, in aicardi‐Goutières syndrome
van Heteren, J., Rozenberg, F., Aronica, E., Troost, D., Lebon, P., & Kuijpers, T. W. (2008) · Glia · doi:10.1002/glia.20639 · Cited by 106
“Aicardi-Goutières syndrome (AGS, MIM 225750) is an autosomal recessive disorder manifest in infants which is associated with mutations in nuclease genes (Crow et al., 2006a,b; Rice et al., 2007a,b).”
BackgroundInfluentialcGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model
Xiao, N., Wei, J., Xu, S., Du, H., Huang, M., Zhang, S., Ye, W., Sun, L., & Chen, Q. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.03.001 · Cited by 117
Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
Shrivastav, M., & Niewold, T. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00319 · Cited by 109
Interfaces between cellular responses to DNA damage and cancer immunotherapy
Pilger, D., Seymour, L. W., & Jackson, S. P. (2021) · Genes & Development · doi:10.1101/gad.348314.121 · Cited by 99
“Mutations inTREX1 result in dysregulation of type I IFN production and are associated with the autoimmune disordersAicardi-Goutières syndrome (AGS) and familial chilblain lupus (Crow et al. 2006a; Rice et al. 2007).”
BackgroundLong interspersed nuclear elements (LINE-1): Potential triggers of systemic autoimmune disease
Crow, M. K. (2009) · Autoimmunity · doi:10.3109/08916930903374865 · Cited by 95
“Mutations in TREX1, encoding a DNA exonuclease, have been observed rarely among SLE patients and have been associated with Aicardi-Goutieres syndrome, characterized by skin lesions, autoantibodies, and central nervous system manifestations of SLE along with high levels of type I IFN [57].”
BackgroundZimmermann, N., Wolf, C., Schwenke, R., Lüth, A., Schmidt, F., Engel, K., Lee‐Kirsch, M. A., & Günther, C. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.5077 · Cited by 92
Type I Interferonopathies in Children: An Overview
d’Angelo, D. M., Filippo, P. D., Breda, L., & Chiarelli, F. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.631329 · Cited by 99
“It is a rare form of cutaneous SLE characterized by cold-induced severe vasculitic ulcerative lesions of (fingers, toes) and ears (81, 82).”
BackgroundOrcesi, S., Piana, R. L., & Fazzi, E. M. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn049 · Cited by 95
Therapies in Aicardi–Goutières syndrome
Crow, Y. J., Vanderver, A. L., Orcesi, S., Kuijpers, T. W., & Rice, G. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12115 · Cited by 97
Self-citationBursztejn, A. ‐., Briggs, T. A., Duany, Y. D. T., Anderson, B., O’Sullivan, J., Williams, S. G., Bodemer, C., Fraitag, S., Gebhard, F. T., Leheup, B., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14073 · Cited by 92
Self-citationCheng, M., & Anderson, M. S. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074953 · Cited by 93
“Heterozygous mutations of TREX1 cause both a dominant form of AGS as well as familial chilblain lupus, a monogenic form of cutaneous lupus that presents with acral ulcers of the skin precipitated by cold or wet exposure (56, 57).”
BackgroundType I interferon-mediated autoinflammation and autoimmunity
Kretschmer, S., & Lee‐Kirsch, M. A. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.09.003 · Cited by 88
The role of cytokines in the pathogenesis of cutaneous lupus erythematosus
Robinson, E. S., & Werth, V. P. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.031 · Cited by 86
“Case reports of a genetic mutation in TREX1, a DNA exonuclease, in SLE and a familial form of chilblain lupus point to another genetic cause of LE [38].”
BackgroundHereditary cerebral small vessel diseases: a review
Federico, A., Di Donato, I., Bianchi, S., Di Palma, C., Taglia, I., & Dotti, M. T. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.041 · Cited by 82
“No phenotype has been reported for heterozygous carriers of these mutations, however, a heterozygous TREX1 mutation causing familial chilblain lupus was recently reported [33].”
BackgroundLi, P., Du, J., Goodier, J. L., Hou, J., Kang, J., Kazazian, H. H., Zhao, K., & Yu, X.-F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx178 · Cited by 99
“To confirm the DNA exonuclease activity of TREX1 D200N, we extracted tagged TREX1 protein from eukaryotic HEK293T cells by immunoprecipitation (Figure 1B), rather than purifying it from a prokaryotic expression system as was done in previous studies (25,26,40,41).”
BackgroundMethodRNA degradation in antiviral immunity and autoimmunity
Rigby, R. E., & Rehwinkel, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.001 · Cited by 84
Animal Models of Interferon Signature Positive Lupus
Zhuang, H., Szeto, C. W., Han, S., Yang, L., & Reeves, W. H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00291 · Cited by 82
“Similarly, human loss-of-function mutations in TREX1, a negative regulator of STING (50), cause autoinflammatory disease manifested by severe neurological impairment (encephalopathy, calcification of the basal ganglia) caused by IFN-I production in the central nervous system (Aicardi–Goutieres syndrome) (51).”
BackgroundCrampton, S. P., Morawski, P. A., & Bolland, S. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016451 · Cited by 91
“Finally, loss-of-function mutations in the nucleic acid repair exonuclease TREX cause a severe immune-mediated neurodevelopmental disorder termed Aicardi-Goutieres syndrome, whereas mutations with a milder effect have been linked to chilblain lupus (Rice et al., 2007).”
Migraine and Genetic and Acquired Vasculopathies
Stam, A., Haan, J., van den Maagdenberg, A., Ferrari, M. D., & Terwindt, G. M. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01940.x · Cited by 83
Christmann, M., Tomicic, M. T., Aasland, D., Berdelle, N., & Kaina, B. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq455 · Cited by 82
“Mutations in TREX1 are associated with the human disorders Aicardi–Goutières syndrome (41,42), autosomal dominant retinal vasculopathy with cerebral leucodystrophy (43), systemic lupus erythematosus (44) and familial chilblain lupus (45).”
BackgroundEndogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Cisneros, G. A., Perera, L., Schaaper, R. M., Pedersen, L. C., London, R. E., Pedersen, L. G., & Darden, T. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8082818 · Cited by 77
Single-stranded nucleic acids promote SAMHD1 complex formation
Tüngler, V., Staroske, W., Kind, B., Dobrick, M., Kretschmer, S., Schmidt, F., Krug, C., Lorenz, M., Chara, O., Schwille, P., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0995-3 · Cited by 85
Brooks, P. J., Cheng, T., & Cooper, L. D. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.01.017 · Cited by 80
“In contrast, other heterozygous TREX1 mutations do not result in neurologic disease, but instead cause the autoimmune disease systemic lupus erythromatosus (SLE) [55], and a dominant negative TREX1 mutation results in the related disorder familial chilblain lupus (FCL) [56,57].”
BackgroundDominant Mutations of the TREX1 Exonuclease Gene in Lupus and Aicardi-Goutières Syndrome
Fye, J. M., Orebaugh, C. D., Coffin, S. R., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276287 · Cited by 84
Self-citationAicardi–Goutières syndrome: a model disease for systemic autoimmunity
Lee‐Kirsch, M. A., Wolf, C., & Günther, C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12160 · Cited by 83
Lo, M. S. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0621-9 · Cited by 76
“As is the case with TREX1, mutations in SAMHD1, ADAR and IFIH1 have also been reported in SLE patients [20, 50].”
BackgroundInfluentialGünther, C., Berndt, N., Wolf, C., & Lee‐Kirsch, M. A. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3438 · Cited by 75
Extracellular DNA and autoimmune diseases
Lou, H., & Pickering, M. C. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.136 · Cited by 71
TREX1 as a Novel Immunotherapeutic Target
Hemphill, W. O., Simpson, S. R., Liu, M., Salsbury, F. R., Hollis, T., Grayson, J. M., & Perrino, F. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660184 · Cited by 76
“Structure includes only the TREX1 catalytic domain (1-242).”
BackgroundSelf-citationAicardi–Goutières syndrome: A monogenic type I interferonopathy
Liu, A., & Ying, S. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13314 · Cited by 78
Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells
Wiser, C. L., Kim, B., Vincent, J., & Ascano, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-64348-y · Cited by 69
Braunstein, I., Goodman, N. G., Rosenbach, M. A., Okawa, J., Shah, A., Krathen, M., Kovarik, C., Prak, E. T. L., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.01.015 · Cited by 63
de Carvalho, L. M., Ngoumou, G. B., Park, J. W., Ehmke, N., Deigendesch, N., Kitabayashi, N., Melki, I., de Souza, F. F. L., Tzschach, A., Nogueira‐Barbosa, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40179 · Cited by 65
“However, arthropathy has been noted in individual reports of patients with dysfunction of SAM domain and HD domain–containing protein 1 (21–24), 30 repair exonuclease 1 (25,26), stimulator of IFN genes (27,28), retinoic acid–inducible gene 1 (29), and proteasome subunit b type 8 (30) (results available upon request fr…”
Self-citationLindahl, T. L., Barnes, D. E., Yang, Y., & Robins, P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370535 · Cited by 74
Self-citationInterferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus
Crow, M. K. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.12.008 · Cited by 67
Aicardi–Goutières syndrome (AGS)
Stephenson, J. B. P. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2007.11.010 · Cited by 62
Type I interferon dysregulation and neurological disease
McGlasson, S. L., Jury, A., Jackson, A. P., & Hunt, D. P. J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.143 · Cited by 62
Neuropathology and Genetics of Cerebroretinal Vasculopathies
Kolar, G. R., Kothari, P. H., Khanlou, N., Jen, J. C., Schmidt, R. E., & Vinters, H. V. (2014) · Brain Pathology · doi:10.1111/bpa.12178 · Cited by 59
“Mutations in TREX1 are implicated in several diseases besides CRV, including Aicardi-Goutieres syndrome (3), familial chilblain lupus (10, 21) and a small percentage of systemic lupus erythematosus patients (11, 15).”
Background
Metadata
- Authors
- Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., Herrick, A. L., Bowden, A. P., Perrino, F. W., Lindahl, T., Barnes, D. E., & Crow, Y. J.
- Affiliations
- St James's University Hospital (GB)
- St Mary's Hospital (GB)
- National Health Service (GB)
- Cancer Research UK (GB)
- Wake Forest University Health Sciences (US)
- Royal Aberdeen Children's Hospital (GB)
- Salford Royal Hospital (GB)
- Rochdale Infirmary (GB)
- Corresponding author
- Crow, Yanick J.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 80
- Issue
- 4
- Pages
- 811-815
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1852703
- OpenAlex
- W2171946670
- Cited by
- 410
- References
- 24
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 37 · 2023: 13 · 2022: 22 · 2021: 31 · 2020: 19 · 2019: 17 · 2018: 15 · 2017: 20 · 2016: 19 · 2015: 25 · 2014: 26 · 2013: 31 · 2012: 28
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2301 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TREX1, chilblain lupus, Aicardi-Goutières syndrome, heterozygous mutation, de novo mutations, 3'-5' exonuclease, systemic lupus erythematosus, autoinflammatory disease, catalytic residues
- MeSH terms
- Basal Ganglia Diseases, Base Sequence, Cell Line, Exodeoxyribonucleases, Female, Humans, Lupus Erythematosus, Systemic, Male, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Syndrome, Sequence Analysis, DNA, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.